# Single Rising Dose Study Investigating the Safety, Tolerability and Pharmacokinetics of Spray Dried BIBN 4096 BS After Inhalation Administration in Healthy Male and Female Volunteers

> **NCT02199860** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 63 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** SD I
- **DRUG:** SD II
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02199860
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05
- **Primary completion:** 2004-02
- **Final completion:** —
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2014-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02199860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02199860, "Single Rising Dose Study Investigating the Safety, Tolerability and Pharmacokinetics of Spray Dried BIBN 4096 BS After Inhalation Administration in Healthy Male and Female Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02199860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*